Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

JAK2 anticorps (AA 120-367)

Cet anticorps Lapin Polyclonal détecte spécifiquement JAK2 dans WB, IHC, ICC et IP. Il présente une réactivité envers Souris.
N° du produit ABIN1176454

Aperçu rapide pour JAK2 anticorps (AA 120-367) (ABIN1176454)

Antigène

Voir toutes JAK2 Anticorps
JAK2 (Janus Kinase 2 (JAK2))

Reactivité

  • 149
  • 91
  • 87
  • 19
  • 18
  • 3
  • 2
  • 2
  • 1
Souris

Hôte

  • 153
  • 6
  • 1
Lapin

Clonalité

  • 140
  • 20
Polyclonal

Conjugué

  • 85
  • 13
  • 7
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Cet anticorp JAK2 est non-conjugé

Application

  • 122
  • 72
  • 58
  • 53
  • 29
  • 27
  • 23
  • 22
  • 21
  • 12
  • 10
  • 4
  • 4
  • 2
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunoprecipitation (IP)
  • Épitope

    • 29
    • 27
    • 16
    • 16
    • 7
    • 6
    • 6
    • 6
    • 5
    • 4
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 120-367

    Fonction

    Polyclonal Antibody to Janus Kinase 2 (JAK2)

    Specificité

    The antibody is a rabbit polyclonal antibody raised against JAK2. It has been selected for its ability to recognize JAK2 in immunohistochemical staining and western blotting.

     Réactivité croisée

    Humain, Rat

    Purification

    Antigen-specific affinity chromatography followed by Protein A affinity chromatography

    Immunogène

    RPF494Mu01Recombinant Janus Kinase 2 (JAK2)

    Isotype

    IgG
  • Indications d'application

    Western blotting: 0.5-2 μg/mL,Immunohistochemistry: 5-20 μg/mL,Immunocytochemistry: 5-20 μg/mL,Optimal working dilutions must be determined by end user.

    Commentaires

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    0.5 mg/mL

    Buffer

    0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.

    Agent conservateur

    ProClin

    Précaution d'utilisation

    WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.

    Conseil sur la manipulation

    Avoid repeated freeze-thaw cycles.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

    Date de péremption

    12 months
  • Antigène

    JAK2 (Janus Kinase 2 (JAK2))

    Autre désignation

    JAK2

    Sujet

    JTK10, Tyrosine-protein kinase JAK2

    Pathways

    Signalistation JAK/STAT, Signalisation RTK, Interferon-gamma Pathway, Positive Regulation of Peptide Hormone Secretion, Intracellular Steroid Hormone Receptor Signaling Pathway, Response to Growth Hormone Stimulus, Positive Regulation of Endopeptidase Activity, Protein targeting to Nucleus, CXCR4-mediated Signaling Events, Platelet-derived growth Factor Receptor Signaling, Unfolded Protein Response
Vous êtes ici:
Chat with us!